Addus HomeCare (ADUS) Financials

$92.74 -1.03 (-1.09%)

As of 01:21 PM Eastern

Annual Income Statements for Addus HomeCare

This table shows Addus HomeCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	12	12	12	16	25	33	45	46	63	74	96
Consolidated Net Income / (Loss)	12	12	12	16	25	33	45	46	63	74	96
Net Income / (Loss) Continuing Operations	11	12	12	16	26	33	45	46	63	74	96
Total Pre-Tax Income	15	16	21	20	33	42	60	60	81	99	127
Total Operating Income	16	15	25	23	35	45	66	69	91	103	139
Total Gross Profit	87	99	116	137	179	226	270	300	340	375	462
Total Revenue	337	401	426	517	649	765	864	951	1,059	1,155	1,423
Operating Revenue	337	401	426	517	649	765	864	951	1,059	1,155	1,423
Total Cost of Revenue	250	302	310	380	470	539	595	651	719	780	961
Operating Cost of Revenue	245	295	310	380	470	539	595	651	719	780	961
Total Operating Expenses	71	83	91	114	144	182	204	231	249	272	323
Selling, General & Admin Expense	66	77	77	105	134	170	189	217	235	259	307
Depreciation Expense	4.72	6.65	6.66	8.64	11	12	14	14	14	14	16
Total Other Income / (Expense), net	-0.74	0.69	-4.19	-2.42	-1.58	-2.57	-5.54	-8.57	-9.63	-3.34	-11
Interest Expense	0.79	2.33	4.47	5.02	3.11	3.19	5.81	8.91	11	7.73	14
Interest & Investment Income	0.05	2.81	0.07	2.59	1.52	0.62	0.27	0.34	1.48	4.39	2.44
Income Tax Expense	3.93	4.10	9.26	4.10	7.36	8.81	15	14	19	26	32
Basic Earnings per Share	$1.06	$1.07	$1.04	$1.36	$1.83	$2.12	$2.87	$2.90	$3.91	$4.33	$5.31
Weighted Average Basic Shares Outstanding	10.99M	11.29M	11.47M	12.05M	13.82M	15.60M	15.74M	15.86M	16.00M	17.01M	18.05M
Diluted Earnings per Share	$1.04	$1.07	$1.03	$1.33	$1.77	$2.08	$2.81	$2.84	$3.83	$4.23	$5.22
Weighted Average Diluted Shares Outstanding	11.19M	11.35M	11.62M	12.38M	14.25M	15.96M	16.06M	16.18M	16.31M	17.38M	18.39M
Weighted Average Basic & Diluted Shares Outstanding	11M	11.30M	11.50M	12.10M	13.82M	15.60M	15.95M	16.13M	16.23M	18.17M	18.52M

This table shows Addus HomeCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	15	20	16	18	20	20	21	22	23	30	25
Consolidated Net Income / (Loss)	15	20	16	18	20	20	21	22	23	30	25
Net Income / (Loss) Continuing Operations	15	20	16	18	20	20	21	22	23	30	25
Total Pre-Tax Income	20	25	21	25	27	26	27	30	30	40	32
Total Operating Income	23	28	24	26	26	27	31	33	33	42	34
Total Gross Profit	87	92	88	93	92	101	108	114	117	124	116
Total Revenue	271	276	281	287	290	297	338	349	362	373	364
Operating Revenue	271	276	281	287	290	297	338	349	362	373	364
Total Cost of Revenue	184	184	193	194	198	196	230	236	246	249	248
Operating Cost of Revenue	184	184	193	194	198	196	230	236	246	249	248
Total Operating Expenses	64	64	65	67	66	75	77	81	84	81	82
Selling, General & Admin Expense	60	61	61	64	63	71	73	77	79	77	78
Depreciation Expense	3.62	3.68	3.47	3.40	3.45	3.21	3.94	3.91	4.41	4.15	4.03
Total Other Income / (Expense), net	-2.62	-2.62	-2.34	-1.64	1.34	-0.70	-3.52	-2.94	-2.58	-2.13	-1.64
Interest Expense	3.20	3.12	2.76	2.11	0.57	2.29	4.02	3.53	3.34	2.73	2.15
Interest & Investment Income	0.58	0.50	0.42	0.47	1.91	1.59	0.50	0.58	0.76	0.60	0.51
Income Tax Expense	4.81	5.78	5.48	6.46	7.13	6.69	5.77	7.89	7.51	10	7.36
Basic Earnings per Share	$0.96	$1.23	$0.99	$1.12	$1.13	$1.09	$1.18	$1.22	$1.26	$1.65	$1.38
Weighted Average Basic Shares Outstanding	16.01M	16.00M	16.06M	16.18M	17.87M	17.01M	17.98M	18.05M	18.07M	18.05M	18.19M
Diluted Earnings per Share	$0.95	$1.19	$0.97	$1.10	$1.10	$1.06	$1.16	$1.20	$1.24	$1.62	$1.36
Weighted Average Diluted Shares Outstanding	16.29M	16.31M	16.37M	16.50M	18.26M	17.38M	18.31M	18.33M	18.39M	18.39M	18.49M
Weighted Average Basic & Diluted Shares Outstanding	16.21M	16.23M	16.37M	18.10M	18.13M	18.17M	18.40M	18.41M	18.48M	18.52M	18.66M

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-9.26	3.91	46	17	41	33	24	-89	-15	34	-17
Net Cash From Operating Activities	4.11	-0.74	53	33	12	109	39	105	112	116	112
Net Cash From Continuing Operating Activities	4.11	-0.74	53	33	12	109	39	105	112	116	112
Net Income / (Loss) Continuing Operations	12	12	12	16	25	33	45	46	63	74	96
Consolidated Net Income / (Loss)	12	12	12	16	25	33	45	46	63	74	96
Depreciation Expense	4.72	6.65	6.66	8.64	11	12	14	14	14	14	16
Amortization Expense	0.10	0.36	1.87	0.61	0.72	0.74	0.80	0.86	0.86	1.05	1.29
Non-Cash Adjustments To Reconcile Net Income	6.01	11	9.99	4.42	6.11	28	-18	21	3.46	19	18
Changes in Operating Assets and Liabilities, net	-18	-31	22	3.10	-31	36	-3.42	23	31	9.22	-21
Net Cash From Investing Activities	-11	-22	-24	-68	-189	-214	-42	-107	-119	-355	-33
Net Cash From Continuing Investing Activities	-11	-22	-24	-68	-189	-214	-42	-107	-119	-355	-33
Purchase of Property, Plant & Equipment	-2.21	-1.71	-3.62	-5.35	-4.62	-6.83	-4.65	-8.30	-9.45	-6.05	-7.72
Acquisitions	-8.51	-20	-24	-62	-184	-208	-37	-98	-110	-354	-32
Sale of Property, Plant & Equipment	-	-	3.70	-	-	-	0.00	0.00	0.02	0.03	0.02
Divestitures	-	-	-	0.00	0.00	0.26	0.00	0.00	0.00	5.36	6.79
Net Cash From Financing Activities	-2.64	26	17	51	218	138	26	-87	-8.18	272	-96
Net Cash From Continuing Financing Activities	-2.64	26	17	51	218	138	26	-87	-8.18	272	-96
Repayment of Debt	-2.22	-30	-77	-106	-1.11	-0.74	-21	-137	-119	-140	-110
Issuance of Debt	-	52	95	80	43	135	46	47	110	233	11
Issuance of Common Equity	-	-	0.00	77	173	0.00	0.00	0.00	0.00	176	0.00
Other Financing Activities, net	-0.43	4.01	-0.27	-0.02	3.09	3.92	1.11	2.55	0.32	3.44	2.48
Cash Interest Paid	0.79	2.32	2.26	4.34	2.32	2.37	5.09	7.99	10	6.52	12
Cash Income Taxes Paid	0.91	5.09	6.73	4.10	7.30	11	18	1.48	15	26	13

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-4.44	-15	12	97	50	-124	-1.96	-5.78	11	-20	21
Net Cash From Operating Activities	22	30	39	19	49	10	19	23	51	19	52
Net Cash From Continuing Operating Activities	22	30	39	19	49	10	19	23	51	19	52
Net Income / (Loss) Continuing Operations	15	20	16	18	20	20	21	22	23	30	25
Consolidated Net Income / (Loss)	15	20	16	18	20	20	21	22	23	30	25
Depreciation Expense	3.62	3.68	3.47	3.40	3.45	3.21	3.94	3.91	4.41	4.15	4.03
Amortization Expense	0.22	0.22	0.22	0.22	0.21	0.41	0.32	0.32	0.33	0.33	0.33
Non-Cash Adjustments To Reconcile Net Income	0.63	0.64	11	2.57	3.81	2.03	0.98	3.99	2.52	11	8.29
Changes in Operating Assets and Liabilities, net	1.91	5.94	8.54	-5.46	21	-15	-7.52	-7.74	21	-26	15
Net Cash From Investing Activities	-111	-5.30	-1.75	3.55	-1.92	-354	-1.38	1.70	-23	-10	-1.69
Net Cash From Continuing Investing Activities	-111	-5.30	-1.75	3.55	-1.92	-354	-1.38	1.70	-23	-10	-1.69
Purchase of Property, Plant & Equipment	-2.36	-5.32	-1.35	-1.07	-1.93	-1.70	-1.88	-1.25	-1.92	-2.66	-1.71
Acquisitions	-109	0.00	-0.40	-	-	-354	-3.35	-	-21	-7.40	0.00
Sale of Property, Plant & Equipment	-	0.02	0.00	-	0.01	-	0.01	0.01	-0.01	0.01	0.02
Divestitures	-	-	0.00	-	-	0.76	3.85	2.94	-	-	0.00
Net Cash From Financing Activities	85	-40	-25	74	2.94	220	-20	-30	-18	-29	-29
Net Cash From Continuing Financing Activities	85	-40	-25	74	2.94	220	-20	-30	-18	-29	-29
Repayment of Debt	-25	-40	-25	-101	-0.04	-13	-20	-30	-30	-30	-30
Other Financing Activities, net	-	0.29	0.00	-	2.98	0.45	0.49	-0.00	0.99	1.00	0.79
Cash Interest Paid	2.95	2.89	2.53	1.96	0.31	1.72	3.74	3.28	3.05	2.39	1.80
Cash Income Taxes Paid	3.80	4.42	0.01	14	5.45	6.82	-0.01	4.87	4.38	3.38	0.00

This table presents Addus HomeCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	186	230	272	348	637	893	948	938	1,024	1,413	1,437
Total Current Assets	94	131	156	176	269	288	324	223	200	260	269
Cash & Equivalents	4.10	8.01	54	70	112	145	169	80	65	99	82
Accounts Receivable	85	117	94	98	150	133	137	126	115	123	152
Prepaid Expenses	4.86	6.00	8.38	7.29	7.99	9.97	18	17	20	39	36
Plant, Property, & Equipment, net	8.62	6.65	7.49	11	12	20	18	21	24	25	25
Total Noncurrent Assets	83	92	109	161	355	585	605	694	800	1,128	1,143
Goodwill	69	73	90	135	275	469	504	583	663	971	997
Intangible Assets	10	15	17	24	57	72	64	72	92	110	102
Other Noncurrent Operating Assets	1.34	-	-	0.00	21	38	36	39	45	47	44
Total Liabilities & Shareholders' Equity	186	230	272	348	637	893	948	938	1,024	1,413	1,437
Total Liabilities	44	72	95	80	161	374	373	304	318	442	352
Total Current Liabilities	42	50	55	62	88	144	118	131	145	156	149
Accounts Payable	4.75	4.49	7.38	12	20	24	19	22	26	27	17
Accrued Expenses	35	43	45	34	53	73	81	72	90	91	94
Current Employee Benefit Liabilities	-	-	-	15	14	14	13	13	12	14	14
Other Current Liabilities	1.25	-	-	-	0.00	32	4.17	24	17	24	25
Total Noncurrent Liabilities	1.88	22	40	18	74	230	256	173	173	286	203
Long-Term Debt	1.88	22	40	17	59	194	221	132	124	218	121
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	0.00	0.00	8.53	26	44
Other Noncurrent Operating Liabilities	-	-	0.45	0.88	14	36	35	42	40	42	37
Total Equity & Noncontrolling Interests	142	158	176	268	476	519	574	634	707	970	1,085
Total Preferred & Common Equity	142	158	176	268	476	519	574	634	707	970	1,085
Total Common Equity	142	158	176	268	476	519	574	634	707	970	1,085
Common Stock	87	92	96	178	360	370	380	393	404	594	613
Retained Earnings	55	65	80	91	116	149	194	240	303	376	472

This table presents Addus HomeCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	946	931	928	1,036	1,014	1,117	1,153	1,408	1,409	1,423	1,436
Total Current Assets	240	209	208	211	192	295	333	258	263	261	273
Cash & Equivalents	106	74	84	80	77	173	223	97	91	102	103
Accounts Receivable	126	125	104	121	105	109	97	135	140	134	145
Prepaid Expenses	8.25	10	19	10	10	12	13	26	32	25	25
Plant, Property, & Equipment, net	17	20	20	21	24	23	24	25	24	24	25
Total Noncurrent Assets	688	702	701	804	798	798	796	1,125	1,121	1,138	1,138
Goodwill	575	584	584	663	663	664	664	972	970	989	997
Intangible Assets	73	71	69	94	90	88	87	108	106	104	100
Other Noncurrent Operating Assets	41	47	48	47	45	46	46	45	46	45	41
Total Liabilities & Shareholders' Equity	946	931	928	1,036	1,014	1,117	1,153	1,408	1,409	1,423	1,436
Total Liabilities	331	282	262	351	289	195	205	412	387	373	320
Total Current Liabilities	128	125	134	140	142	148	158	148	151	157	149
Accounts Payable	20	22	21	21	22	20	28	28	16	17	14
Accrued Expenses	75	68	80	87	83	91	92	85	101	107	94
Current Employee Benefit Liabilities	13	13	12	12	12	12	13	14	13	14	13
Other Current Liabilities	21	22	21	19	25	24	25	21	21	19	28
Total Noncurrent Liabilities	203	158	128	212	147	47	47	264	236	216	170
Long-Term Debt	164	108	79	164	99	0.00	0.00	199	169	151	91
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	26	26	26	44
Other Noncurrent Operating Liabilities	39	49	49	48	48	47	47	40	40	39	35
Total Equity & Noncontrolling Interests	615	649	666	684	725	922	948	995	1,022	1,050	1,116
Total Preferred & Common Equity	615	649	666	684	725	922	948	995	1,022	1,050	1,116
Total Common Equity	615	649	666	684	725	922	948	995	1,022	1,050	1,116
Common Stock	389	396	399	401	406	585	591	598	602	607	619
Retained Earnings	226	253	268	283	319	337	357	398	420	443	497

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.63%	19.04%	6.25%	21.28%	25.58%	17.88%	13.04%	10.02%	11.31%	9.06%	23.21%
EBITDA Growth	-5.52%	8.87%	49.87%	-5.66%	43.54%	24.44%	41.78%	2.98%	26.64%	10.69%	33.30%
EBIT Growth	-11.33%	-2.13%	62.42%	-10.38%	52.24%	28.07%	48.15%	4.25%	32.32%	12.90%	34.98%
NOPAT Growth	-4.25%	-2.95%	22.53%	28.90%	48.22%	30.02%	40.12%	6.73%	32.98%	8.80%	37.13%
Net Income Growth	-5.06%	4.62%	-1.70%	37.48%	53.58%	31.29%	36.20%	1.99%	35.83%	17.73%	30.32%
EPS Growth	-5.45%	2.88%	-3.74%	29.13%	33.08%	17.51%	35.10%	1.07%	34.86%	10.44%	23.40%
Operating Cash Flow Growth	-41.58%	-118.10%	7,202.42%	-37.08%	-63.80%	810.32%	-63.91%	166.18%	6.79%	3.73%	-4.23%
Free Cash Flow Firm Growth	-38.77%	-116.14%	199.57%	-240.48%	-473.73%	39.60%	92.12%	25.67%	-67.87%	-2,202.93%	128.11%
Invested Capital Growth	19.05%	24.44%	-4.80%	30.12%	96.76%	34.15%	10.18%	9.42%	11.77%	42.29%	3.18%
Revenue Q/Q Growth	0.63%	5.01%	2.00%	5.29%	9.11%	0.48%	3.43%	2.41%	2.85%	1.83%	5.64%
EBITDA Q/Q Growth	-9.33%	33.25%	-2.73%	-3.33%	29.41%	-4.73%	11.52%	1.27%	7.45%	-1.12%	11.58%
EBIT Q/Q Growth	-12.20%	48.55%	-4.33%	-5.10%	35.97%	-5.95%	13.11%	2.16%	8.54%	-1.02%	12.47%
NOPAT Q/Q Growth	-4.18%	27.31%	-24.63%	16.43%	33.69%	-5.45%	11.51%	5.29%	7.37%	-1.95%	12.16%
Net Income Q/Q Growth	-4.92%	56.36%	-33.86%	13.95%	39.45%	-6.46%	11.38%	3.84%	8.35%	-0.07%	11.97%
EPS Q/Q Growth	-4.59%	55.07%	-34.39%	10.83%	33.08%	-7.56%	11.07%	2.90%	8.19%	-2.98%	12.02%
Operating Cash Flow Q/Q Growth	-50.07%	-102.82%	386.64%	-4.79%	-27.63%	41.66%	-21.65%	-0.86%	5.41%	-14.43%	8.09%
Free Cash Flow Firm Q/Q Growth	-992.96%	-2,727.78%	244.23%	13.18%	-271.42%	-53.98%	95.29%	-279.90%	64.85%	-304.39%	124.81%
Invested Capital Q/Q Growth	11.58%	28.71%	-2.33%	-2.79%	45.83%	42.50%	0.00%	1.87%	-0.32%	50.39%	2.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	25.83%	24.68%	27.20%	26.48%	27.63%	29.58%	31.21%	31.51%	32.10%	32.48%	32.47%
EBITDA Margin	6.19%	5.66%	7.98%	6.21%	7.10%	7.49%	9.40%	8.80%	10.01%	10.16%	10.99%
Operating Margin	4.76%	3.86%	5.93%	4.42%	5.36%	5.82%	7.63%	7.23%	8.59%	8.89%	9.74%
EBIT Margin	4.76%	3.91%	5.98%	4.42%	5.36%	5.82%	7.63%	7.23%	8.59%	8.89%	9.74%
Profit (Net Income) Margin	3.45%	3.03%	2.81%	3.18%	3.89%	4.33%	5.22%	4.84%	5.91%	6.37%	6.74%
Tax Burden Percent	76.04%	75.24%	56.75%	80.54%	76.08%	79.00%	74.71%	76.49%	76.87%	74.08%	75.26%
Interest Burden Percent	95.39%	103.06%	82.70%	89.38%	95.45%	94.24%	91.60%	87.54%	89.41%	96.75%	91.94%
Effective Tax Rate	25.72%	25.36%	43.95%	20.08%	22.19%	21.00%	25.29%	23.51%	23.13%	25.92%	24.74%
Return on Invested Capital (ROIC)	9.26%	7.37%	8.34%	9.58%	8.46%	7.09%	8.25%	8.02%	9.63%	8.20%	9.42%
ROIC Less NNEP Spread (ROIC-NNEP)	13.68%	16.01%	-74.63%	15.25%	11.90%	206.92%	0.12%	-4.60%	-3.69%	5.43%	-1.16%
Return on Net Nonoperating Assets (RNNOA)	-0.64%	0.75%	-1.19%	-2.19%	-1.68%	-0.42%	0.01%	-0.40%	-0.31%	0.58%	-0.09%
Return on Equity (ROE)	8.62%	8.12%	7.16%	7.39%	6.78%	6.66%	8.26%	7.62%	9.33%	8.78%	9.33%
Cash Return on Invested Capital (CROIC)	-8.13%	-14.41%	13.26%	-16.60%	-56.75%	-22.08%	-1.44%	-0.98%	-1.48%	-26.71%	6.29%
Operating Return on Assets (OROA)	8.74%	7.55%	10.16%	7.37%	7.06%	5.82%	7.17%	7.29%	9.27%	8.43%	9.73%
Return on Assets (ROA)	6.34%	5.85%	4.77%	5.30%	5.13%	4.33%	4.90%	4.88%	6.37%	6.04%	6.73%
Return on Common Equity (ROCE)	8.62%	8.12%	7.16%	7.39%	6.78%	6.66%	8.26%	7.62%	9.33%	8.78%	9.33%
Return on Equity Simple (ROE_SIMPLE)	8.20%	7.71%	6.78%	6.12%	5.31%	6.39%	7.86%	7.26%	8.85%	7.58%	0.00%
Net Operating Profit after Tax (NOPAT)	12	12	14	18	27	35	49	53	70	76	104
NOPAT Margin	3.53%	2.88%	3.32%	3.53%	4.17%	4.60%	5.70%	5.53%	6.60%	6.59%	7.33%
Net Nonoperating Expense Percent (NNEP)	-4.42%	-8.65%	82.97%	-5.67%	-3.44%	-199.83%	8.13%	12.62%	13.32%	2.76%	10.58%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	6.87%	8.42%	6.40%	8.65%
Cost of Revenue to Revenue	74.17%	75.32%	72.80%	73.52%	72.37%	70.42%	68.79%	68.49%	67.90%	67.52%	67.53%
SG&A Expenses to Revenue	19.64%	19.17%	18.05%	20.39%	20.64%	22.19%	21.91%	22.81%	22.18%	22.41%	21.57%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.08%	20.82%	21.27%	22.06%	22.27%	23.76%	23.59%	24.29%	23.51%	23.59%	22.72%
Earnings before Interest and Taxes (EBIT)	16	16	25	23	35	45	66	69	91	103	139
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	23	34	32	46	57	81	84	106	117	156
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.82	2.55	2.30	3.31	3.18	3.57	2.59	2.53	2.13	2.34	1.83
Price to Tangible Book Value (P/TBV)	4.14	5.76	5.83	8.14	10.57	0.00	264.50	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.77	1.00	0.95	1.72	2.33	2.42	1.72	1.69	1.42	1.97	1.40
Price to Earnings (P/E)	22.25	33.04	33.86	54.11	59.94	55.87	33.00	34.83	24.08	30.88	20.70
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.49%	3.03%	2.95%	1.85%	1.67%	1.79%	3.03%	2.87%	4.15%	3.24%	4.83%
Enterprise Value to Invested Capital (EV/IC)	1.84	2.40	2.38	3.88	3.45	3.34	2.46	2.41	2.04	2.19	1.80
Enterprise Value to Revenue (EV/Rev)	0.76	1.04	0.92	1.62	2.25	2.49	1.78	1.74	1.48	2.07	1.42
Enterprise Value to EBITDA (EV/EBITDA)	12.31	18.42	11.59	26.06	31.73	33.18	18.97	19.78	14.77	20.40	12.95
Enterprise Value to EBIT (EV/EBIT)	16.01	26.65	15.47	36.62	42.04	42.71	23.38	24.07	17.20	23.30	14.60
Enterprise Value to NOPAT (EV/NOPAT)	21.56	36.18	27.84	45.82	54.02	54.06	31.29	31.47	22.38	31.45	19.41
Enterprise Value to Operating Cash Flow (EV/OCF)	62.49	0.00	7.47	25.18	121.55	17.37	39.03	15.74	13.94	20.55	18.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	17.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	29.04
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.16	0.24	0.06	0.13	0.38	0.38	0.21	0.18	0.23	0.11
Long-Term Debt to Equity	0.01	0.14	0.23	0.06	0.12	0.37	0.38	0.21	0.18	0.23	0.11
Financial Leverage	-0.05	0.05	0.02	-0.14	-0.14	0.00	0.09	0.09	0.08	0.11	0.08
Leverage Ratio	1.36	1.39	1.50	1.39	1.32	1.54	1.68	1.56	1.46	1.45	1.39
Compound Leverage Factor	1.30	1.43	1.24	1.25	1.26	1.45	1.54	1.37	1.31	1.41	1.27
Debt to Total Capital	2.07%	13.69%	19.59%	6.05%	11.18%	27.31%	27.78%	17.22%	14.94%	18.37%	10.03%
Short-Term Debt to Total Capital	0.77%	1.38%	1.41%	0.02%	0.14%	0.14%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	1.30%	12.30%	18.18%	6.03%	11.05%	27.17%	27.78%	17.22%	14.94%	18.37%	10.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	97.93%	86.31%	80.41%	93.95%	88.82%	72.69%	72.22%	82.78%	85.06%	81.63%	89.97%
Debt to EBITDA	0.14	1.10	1.26	0.54	1.30	3.40	2.72	1.58	1.17	1.86	0.77
Net Debt to EBITDA	-0.10	0.71	-0.32	-1.66	-1.13	0.87	0.64	0.62	0.56	1.02	0.25
Long-Term Debt to EBITDA	0.09	0.99	1.17	0.54	1.29	3.38	2.72	1.58	1.17	1.86	0.77
Debt to NOPAT	0.25	2.17	3.04	0.95	2.21	5.54	4.48	2.51	1.78	2.87	1.16
Net Debt to NOPAT	-0.17	1.39	-0.76	-2.91	-1.92	1.42	1.06	0.99	0.85	1.57	0.38
Long-Term Debt to NOPAT	0.16	1.95	2.82	0.94	2.19	5.51	4.48	2.51	1.78	2.87	1.16
Altman Z-Score	6.36	6.14	5.28	9.16	7.43	4.42	4.08	4.89	4.65	4.60	5.25
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.23	2.64	2.83	2.86	3.08	2.00	2.76	1.70	1.38	1.67	1.80
Quick Ratio	2.11	2.52	2.67	2.74	2.99	1.93	2.60	1.57	1.24	1.42	1.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-10	-23	23	-32	-181	-110	-8.63	-6.41	-11	-248	70
Operating Cash Flow to CapEx	185.54%	-43.40%	0.00%	620.73%	260.10%	1,601.68%	850.12%	1,266.39%	1,189.18%	1,933.80%	1,447.39%
Free Cash Flow to Firm to Interest Expense	-13.30	-9.69	5.03	-6.30	-58.41	-34.35	-1.49	-0.72	-0.97	-32.06	5.12
Operating Cash Flow to Interest Expense	5.22	-0.32	11.80	6.62	3.87	34.31	6.80	11.80	10.11	15.06	8.19
Operating Cash Flow Less CapEx to Interest Expense	2.41	-1.05	11.82	5.55	2.38	32.17	6.00	10.87	9.26	14.28	7.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.84	1.93	1.70	1.67	1.32	1.00	0.94	1.01	1.08	0.95	1.00
Accounts Receivable Turnover	4.39	3.97	4.05	5.39	5.23	5.42	6.41	7.25	8.79	9.69	10.36
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	41.29	52.52	60.27	56.94	56.88	47.94	45.22	47.96	46.85	47.40	57.24
Accounts Payable Turnover	57.43	65.40	52.27	38.72	29.46	24.85	27.62	31.43	29.78	29.22	43.66
Days Sales Outstanding (DSO)	83.06	91.93	90.19	67.77	69.76	67.37	56.91	50.36	41.55	37.68	35.23
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	6.36	5.58	6.98	9.43	12.39	14.69	13.22	11.61	12.26	12.49	8.36
Cash Conversion Cycle (CCC)	76.70	86.35	83.21	58.34	57.37	52.68	43.70	38.75	29.29	25.19	26.87
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	140	174	166	215	424	568	626	685	766	1,090	1,125
Invested Capital Turnover	2.62	2.56	2.51	2.71	2.03	1.54	1.45	1.45	1.46	1.24	1.28
Increase / (Decrease) in Invested Capital	22	34	-8.35	50	208	145	58	59	81	324	35
Enterprise Value (EV)	257	418	394	836	1,461	1,901	1,541	1,655	1,565	2,393	2,024
Market Capitalization	259	402	405	889	1,513	1,851	1,489	1,603	1,506	2,273	1,985
Book Value per Share	$12.76	$13.76	$15.16	$20.50	$30.57	$32.81	$36.06	$39.33	$43.58	$53.52	$58.72
Tangible Book Value per Share	$5.63	$6.09	$5.96	$8.34	$9.20	($1.39)	$0.35	($1.33)	($2.98)	($6.05)	($0.75)
Total Capital	145	183	219	286	535	714	795	765	831	1,189	1,206
Total Debt	2.99	25	43	17	60	195	221	132	124	218	121
Total Long-Term Debt	1.88	22	40	17	59	194	221	132	124	218	121
Net Debt	-2.01	16	-11	-53	-52	50	52	52	59	120	39
Capital Expenditures (CapEx)	2.21	1.71	-0.09	5.35	4.62	6.83	4.65	8.30	9.44	6.02	7.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)	49	76	50	44	71	-0.31	38	12	-9.90	5.60	38
Debt-free Net Working Capital (DFNWC)	53	84	104	115	183	145	207	92	55	105	120
Net Working Capital (NWC)	52	81	101	115	182	144	207	92	55	105	120
Net Nonoperating Expense (NNE)	0.28	-0.61	2.20	1.81	1.81	2.03	4.14	6.55	7.40	2.47	8.41
Net Nonoperating Obligations (NNO)	-2.01	16	-11	-53	-52	50	52	52	59	120	39
Total Depreciation and Amortization (D&A)	4.81	7.00	8.53	9.25	11	13	15	15	15	15	18
Debt-free, Cash-free Net Working Capital to Revenue	14.47%	18.93%	11.72%	8.55%	10.92%	-0.04%	4.37%	1.23%	-0.94%	0.49%	2.70%
Debt-free Net Working Capital to Revenue	15.69%	20.93%	24.34%	22.18%	28.14%	18.93%	23.90%	9.64%	5.18%	9.05%	8.44%
Net Working Capital to Revenue	15.36%	20.30%	23.61%	22.16%	28.03%	18.80%	23.90%	9.64%	5.18%	9.05%	8.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.06	$1.06	$1.19	$1.45	$1.83	$2.12	$2.87	$2.90	$3.91	$4.33	$5.31
Adjusted Weighted Average Basic Shares Outstanding	10.99M	11.29M	11.47M	12.05M	13.82M	15.60M	15.74M	15.86M	16.00M	17.01M	18.05M
Adjusted Diluted Earnings per Share	$1.04	$1.06	$1.17	$1.41	$1.77	$2.08	$2.81	$2.84	$3.83	$4.23	$5.22
Adjusted Weighted Average Diluted Shares Outstanding	11.19M	11.35M	11.62M	12.38M	14.25M	15.96M	16.06M	16.18M	16.31M	17.38M	18.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.12M	11.53M	11.63M	13.18M	13.82M	15.83M	15.95M	16.13M	16.23M	18.17M	18.52M
Normalized Net Operating Profit after Tax (NOPAT)	12	12	14	18	27	35	49	53	70	76	104
Normalized NOPAT Margin	3.53%	2.88%	3.32%	3.53%	4.17%	4.60%	5.70%	5.53%	6.60%	6.59%	7.33%
Pre Tax Income Margin	4.54%	4.03%	4.94%	3.95%	5.11%	5.48%	6.99%	6.33%	7.68%	8.61%	8.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	20.39	6.72	5.70	4.55	11.19	13.96	11.36	7.72	8.19	13.28	10.18
NOPAT to Interest Expense	15.14	4.95	3.17	3.64	8.71	11.03	8.49	5.90	6.30	9.84	7.66
EBIT Less CapEx to Interest Expense	17.57	5.99	5.71	3.48	9.70	11.81	10.56	6.79	7.34	12.50	9.62
NOPAT Less CapEx to Interest Expense	12.33	4.22	3.18	2.57	7.22	8.88	7.68	4.97	5.45	9.06	7.10
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	18,518,271.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	18,518,271.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.35
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.57%	11.86%	11.58%	10.36%	7.04%	7.52%	20.29%	21.79%	25.02%	25.55%	7.67%
EBITDA Growth	25.99%	29.95%	22.72%	18.54%	11.02%	-4.17%	27.25%	24.58%	27.22%	53.12%	10.51%
EBIT Growth	30.39%	34.38%	27.07%	21.55%	13.63%	-3.78%	29.05%	25.61%	26.91%	57.09%	11.66%
NOPAT Growth	30.23%	28.48%	21.04%	17.56%	10.17%	-7.19%	36.60%	25.57%	29.28%	56.45%	9.77%
Net Income Growth	33.51%	32.62%	24.89%	21.73%	30.84%	-0.27%	34.10%	21.98%	13.32%	52.52%	18.09%
EPS Growth	33.80%	32.22%	24.36%	20.88%	15.79%	-10.92%	19.59%	9.09%	12.73%	52.83%	17.24%
Operating Cash Flow Growth	18.94%	23.70%	105.75%	-54.79%	122.75%	-65.33%	-51.01%	19.75%	5.65%	80.10%	176.35%
Free Cash Flow Firm Growth	-137.37%	-40.08%	-196.97%	-321.83%	180.28%	-414.41%	-601.66%	-379.73%	-655.08%	98.93%	105.88%
Invested Capital Growth	14.23%	11.77%	9.35%	13.24%	-5.69%	42.29%	46.73%	46.95%	51.59%	3.18%	0.66%
Revenue Q/Q Growth	4.13%	2.08%	1.59%	2.20%	1.00%	2.54%	13.65%	3.47%	3.68%	2.97%	-2.54%
EBITDA Q/Q Growth	6.12%	19.45%	-14.23%	9.03%	-0.62%	3.10%	13.90%	6.74%	1.49%	24.10%	-17.80%
EBIT Q/Q Growth	6.04%	22.47%	-15.46%	10.73%	-0.87%	3.70%	13.38%	7.78%	0.15%	28.36%	-19.41%
NOPAT Q/Q Growth	6.10%	24.08%	-18.68%	9.81%	-0.57%	4.53%	19.69%	0.94%	2.37%	26.50%	-16.02%
Net Income Q/Q Growth	3.76%	27.04%	-19.14%	14.21%	11.53%	-3.16%	8.72%	3.88%	3.61%	30.35%	-15.83%
EPS Q/Q Growth	4.40%	25.26%	-18.49%	13.40%	0.00%	-3.64%	9.43%	3.45%	3.33%	30.65%	-16.05%
Operating Cash Flow Q/Q Growth	-47.65%	37.93%	28.72%	-51.36%	157.93%	-78.53%	81.89%	18.89%	127.56%	-63.40%	179.09%
Free Cash Flow Firm Q/Q Growth	-354.84%	24.58%	21.51%	-47.05%	192.23%	-583.25%	-7.06%	-0.54%	-6.71%	99.07%	687.09%
Invested Capital Q/Q Growth	16.29%	-0.32%	-2.38%	0.08%	-3.15%	50.39%	0.66%	0.23%	-0.09%	2.36%	-1.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.04%	33.44%	31.41%	32.47%	31.82%	34.15%	31.88%	32.59%	32.21%	33.13%	31.87%
EBITDA Margin	9.85%	11.53%	9.73%	10.39%	10.22%	10.28%	10.30%	10.62%	10.40%	12.53%	10.57%
Operating Margin	8.44%	10.12%	8.42%	9.12%	8.96%	9.06%	9.04%	9.41%	9.09%	11.33%	9.37%
EBIT Margin	8.44%	10.12%	8.42%	9.12%	8.96%	9.06%	9.04%	9.41%	9.09%	11.33%	9.37%
Profit (Net Income) Margin	5.69%	7.08%	5.64%	6.30%	6.96%	6.57%	6.29%	6.31%	6.31%	7.98%	6.89%
Tax Burden Percent	76.22%	77.22%	74.28%	73.67%	73.89%	74.49%	78.63%	73.64%	75.27%	74.18%	77.30%
Interest Burden Percent	88.53%	90.65%	90.12%	93.74%	105.14%	97.41%	88.48%	91.05%	92.16%	94.96%	95.18%
Effective Tax Rate	23.78%	22.78%	25.72%	26.33%	26.11%	25.51%	21.37%	26.36%	24.73%	25.82%	22.70%
Return on Invested Capital (ROIC)	9.18%	11.40%	9.51%	10.63%	10.05%	8.39%	9.33%	9.56%	10.11%	10.80%	9.53%
ROIC Less NNEP Spread (ROIC-NNEP)	6.37%	7.77%	3.48%	11.99%	8.63%	7.81%	4.89%	14.10%	12.34%	8.81%	6.71%
Return on Net Nonoperating Assets (RNNOA)	0.70%	0.64%	0.15%	-1.35%	-0.73%	0.83%	0.35%	-0.69%	-1.08%	0.68%	0.29%
Return on Equity (ROE)	9.88%	12.05%	9.65%	9.29%	9.32%	9.23%	9.68%	8.86%	9.03%	11.48%	9.82%
Cash Return on Invested Capital (CROIC)	-4.25%	-1.48%	1.26%	-1.65%	16.25%	-26.71%	-28.94%	-28.58%	-30.81%	6.29%	9.04%
Operating Return on Assets (OROA)	8.76%	10.92%	9.42%	9.95%	9.28%	8.58%	9.04%	9.50%	9.51%	11.31%	9.55%
Return on Assets (ROA)	5.91%	7.64%	6.31%	6.87%	7.21%	6.23%	6.29%	6.37%	6.59%	7.97%	7.02%
Return on Common Equity (ROCE)	9.88%	12.05%	9.65%	9.29%	9.32%	9.23%	9.68%	8.86%	9.03%	11.48%	9.82%
Return on Equity Simple (ROE_SIMPLE)	8.43%	0.00%	9.06%	7.48%	7.77%	0.00%	7.94%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	17	22	18	19	19	20	24	24	25	31	26
NOPAT Margin	6.43%	7.82%	6.26%	6.72%	6.62%	6.75%	7.10%	6.93%	6.84%	8.41%	7.24%
Net Nonoperating Expense Percent (NNEP)	2.81%	3.63%	6.03%	-1.35%	1.42%	0.58%	4.44%	-4.54%	-2.23%	1.99%	2.82%
Return On Investment Capital (ROIC_SIMPLE)	-	2.60%	-	-	-	1.69%	2.01%	2.03%	2.07%	2.60%	2.18%
Cost of Revenue to Revenue	67.96%	66.56%	68.59%	67.53%	68.18%	65.85%	68.12%	67.41%	67.79%	66.87%	68.13%
SG&A Expenses to Revenue	22.26%	21.99%	21.75%	22.16%	21.67%	24.01%	21.68%	22.06%	21.91%	20.69%	21.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.60%	23.32%	22.99%	23.34%	22.86%	25.10%	22.85%	23.18%	23.12%	21.80%	22.50%
Earnings before Interest and Taxes (EBIT)	23	28	24	26	26	27	31	33	33	42	34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	27	32	27	30	30	31	35	37	38	47	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.02	2.13	2.31	2.06	2.54	2.34	1.81	2.07	2.07	1.83	1.55
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	11.22	12.20	0.00	0.00	0.00	0.00	0.00	91.31
Price to Revenue (P/Rev)	1.34	1.42	1.54	1.71	2.12	1.97	1.48	1.66	1.61	1.40	1.20
Price to Earnings (P/E)	23.94	24.08	25.52	27.59	32.69	30.88	22.75	25.54	25.36	20.70	17.39
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.18%	4.15%	3.92%	3.62%	3.06%	3.24%	4.40%	3.91%	3.94%	4.83%	5.75%
Enterprise Value to Invested Capital (EV/IC)	1.91	2.04	2.27	2.31	3.01	2.19	1.73	2.00	2.02	1.80	1.56
Enterprise Value to Revenue (EV/Rev)	1.42	1.48	1.56	1.55	1.93	2.07	1.57	1.72	1.65	1.42	1.19
Enterprise Value to EBITDA (EV/EBITDA)	14.86	14.77	15.30	14.94	18.42	20.40	15.23	16.64	15.85	12.95	10.77
Enterprise Value to EBIT (EV/EBIT)	17.49	17.20	17.69	17.17	21.06	23.30	17.33	18.90	18.02	14.60	12.12
Enterprise Value to NOPAT (EV/NOPAT)	22.50	22.38	23.27	22.78	28.16	31.45	23.05	25.16	23.88	19.41	16.14
Enterprise Value to Operating Cash Flow (EV/OCF)	13.76	13.94	12.85	15.80	16.06	20.55	19.64	21.88	21.53	18.15	11.89
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	187.95	0.00	18.01	0.00	0.00	0.00	0.00	29.04	17.31
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.24	0.18	0.14	0.00	0.00	0.23	0.20	0.17	0.14	0.11	0.08
Long-Term Debt to Equity	0.24	0.18	0.14	0.00	0.00	0.23	0.20	0.17	0.14	0.11	0.08
Financial Leverage	0.11	0.08	0.04	-0.11	-0.09	0.11	0.07	-0.05	-0.09	0.08	0.04
Leverage Ratio	1.53	1.46	1.42	1.29	1.34	1.45	1.41	1.30	1.29	1.39	1.35
Compound Leverage Factor	1.35	1.33	1.28	1.21	1.41	1.42	1.25	1.18	1.19	1.32	1.28
Debt to Total Capital	19.32%	14.94%	12.05%	0.00%	0.00%	18.37%	16.64%	14.20%	12.55%	10.03%	7.56%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.32%	14.94%	12.05%	0.00%	0.00%	18.37%	16.64%	14.20%	12.55%	10.03%	7.56%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	80.68%	85.06%	87.95%	100.00%	100.00%	81.63%	83.36%	85.80%	87.45%	89.97%	92.44%
Debt to EBITDA	1.66	1.17	0.90	0.00	0.00	1.86	1.59	1.28	1.08	0.77	0.57
Net Debt to EBITDA	0.85	0.56	0.20	0.00	0.00	1.02	0.82	0.59	0.35	0.25	-0.07
Long-Term Debt to EBITDA	1.66	1.17	0.90	0.00	0.00	1.86	1.59	1.28	1.08	0.77	0.57
Debt to NOPAT	2.52	1.78	1.36	0.00	0.00	2.87	2.41	1.94	1.62	1.16	0.86
Net Debt to NOPAT	1.29	0.85	0.31	0.00	0.00	1.57	1.24	0.89	0.52	0.38	-0.11
Long-Term Debt to NOPAT	2.52	1.78	1.36	0.00	0.00	2.87	2.41	1.94	1.62	1.16	0.86
Altman Z-Score	3.89	4.44	5.13	7.51	8.71	4.43	4.04	4.78	5.04	5.03	4.93
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.51	1.38	1.35	2.00	2.11	1.67	1.74	1.74	1.66	1.80	1.83
Quick Ratio	1.44	1.24	1.28	1.91	2.02	1.42	1.57	1.53	1.50	1.56	1.66
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-78	-59	-46	-68	63	-304	-325	-327	-349	-3.26	19
Operating Cash Flow to CapEx	921.92%	566.43%	2,865.04%	1,756.58%	2,524.71%	613.91%	1,010.07%	1,813.93%	2,656.27%	706.44%	3,094.86%
Free Cash Flow to Firm to Interest Expense	-24.49	-18.97	-16.82	-32.26	109.77	-132.90	-80.99	-92.81	-104.43	-1.20	8.90
Operating Cash Flow to Interest Expense	6.81	9.65	14.02	8.90	84.69	4.56	4.72	6.39	15.34	6.88	24.34
Operating Cash Flow Less CapEx to Interest Expense	6.07	7.94	13.53	8.39	81.33	3.81	4.25	6.04	14.76	5.91	23.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.04	1.08	1.12	1.09	1.04	0.95	1.00	1.01	1.05	1.00	1.02
Accounts Receivable Turnover	8.32	8.79	9.45	10.45	10.42	9.69	10.12	10.22	11.68	10.36	10.37
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	54.26	46.85	49.31	51.86	51.27	47.40	49.89	53.28	55.92	57.24	58.69
Accounts Payable Turnover	34.37	29.78	33.72	36.90	31.28	29.22	32.69	47.88	40.85	43.66	46.58
Days Sales Outstanding (DSO)	43.86	41.55	38.62	34.94	35.04	37.68	36.05	35.71	31.26	35.23	35.21
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	10.62	12.26	10.82	9.89	11.67	12.49	11.17	7.62	8.94	8.36	7.84
Cash Conversion Cycle (CCC)	33.24	29.29	27.79	25.05	23.37	25.19	24.89	28.09	22.32	26.87	27.37
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	769	766	748	748	725	1,090	1,097	1,100	1,099	1,125	1,104
Invested Capital Turnover	1.43	1.46	1.52	1.58	1.52	1.24	1.31	1.38	1.48	1.28	1.32
Increase / (Decrease) in Invested Capital	96	81	64	87	-44	324	349	351	374	35	7.20
Enterprise Value (EV)	1,465	1,565	1,698	1,727	2,185	2,393	1,899	2,197	2,221	2,024	1,722
Market Capitalization	1,381	1,506	1,676	1,901	2,408	2,273	1,797	2,119	2,172	1,985	1,734
Book Value per Share	$42.20	$43.58	$45.14	$56.30	$52.35	$53.52	$54.77	$55.54	$57.04	$58.72	$61.35
Tangible Book Value per Share	($4.47)	($2.98)	($1.77)	$10.35	$10.91	($6.05)	($4.66)	($2.91)	($2.34)	($0.75)	$1.04
Total Capital	848	831	824	922	948	1,189	1,194	1,191	1,201	1,206	1,207
Total Debt	164	124	99	0.00	0.00	218	199	169	151	121	91
Total Long-Term Debt	164	124	99	0.00	0.00	218	199	169	151	121	91
Net Debt	84	59	23	-173	-223	120	102	78	49	39	-12
Capital Expenditures (CapEx)	2.36	5.31	1.35	1.07	1.92	1.70	1.88	1.24	1.93	2.66	1.69
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-8.14	-9.90	-26	-26	-48	5.60	13	20	1.95	38	20
Debt-free Net Working Capital (DFNWC)	72	55	50	147	175	105	110	112	104	120	123
Net Working Capital (NWC)	72	55	50	147	175	105	110	112	104	120	123
Net Nonoperating Expense (NNE)	2.00	2.02	1.73	1.21	-0.99	0.52	2.76	2.17	1.94	1.58	1.27
Net Nonoperating Obligations (NNO)	84	59	23	-173	-223	120	102	78	49	39	-12
Total Depreciation and Amortization (D&A)	3.84	3.89	3.68	3.62	3.66	3.62	4.26	4.23	4.74	4.48	4.36
Debt-free, Cash-free Net Working Capital to Revenue	-0.79%	-0.94%	-2.43%	-2.32%	-4.22%	0.49%	1.07%	1.61%	0.14%	2.70%	1.40%
Debt-free Net Working Capital to Revenue	6.96%	5.18%	4.62%	13.23%	15.43%	9.05%	9.07%	8.76%	7.71%	8.44%	8.52%
Net Working Capital to Revenue	6.96%	5.18%	4.62%	13.23%	15.43%	9.05%	9.07%	8.76%	7.71%	8.44%	8.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.96	$1.23	$0.99	$1.12	$1.13	$1.09	$1.18	$1.22	$1.26	$1.65	$1.38
Adjusted Weighted Average Basic Shares Outstanding	16.01M	16.00M	16.06M	16.18M	17.87M	17.01M	17.98M	18.05M	18.07M	18.05M	18.19M
Adjusted Diluted Earnings per Share	$0.95	$1.19	$0.97	$1.10	$1.10	$1.06	$1.16	$1.20	$1.24	$1.62	$1.36
Adjusted Weighted Average Diluted Shares Outstanding	16.29M	16.31M	16.37M	16.50M	18.26M	17.38M	18.31M	18.33M	18.39M	18.39M	18.49M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	16.21M	16.23M	16.37M	18.10M	18.13M	18.17M	18.40M	18.41M	18.48M	18.52M	18.66M
Normalized Net Operating Profit after Tax (NOPAT)	17	22	18	19	19	20	24	24	25	31	26
Normalized NOPAT Margin	6.43%	7.82%	6.26%	6.72%	6.62%	6.75%	7.10%	6.93%	6.84%	8.41%	7.24%
Pre Tax Income Margin	7.47%	9.17%	7.59%	8.55%	9.42%	8.82%	7.99%	8.57%	8.38%	10.76%	8.92%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.14	8.98	8.57	12.38	45.29	11.77	7.59	9.33	9.85	15.51	15.84
NOPAT to Interest Expense	5.44	6.93	6.37	9.12	33.47	8.77	5.97	6.87	7.42	11.50	12.24
EBIT Less CapEx to Interest Expense	6.40	7.28	8.08	11.88	41.94	11.03	7.13	8.98	9.28	14.53	15.05
NOPAT Less CapEx to Interest Expense	4.70	5.23	5.88	8.62	30.11	8.02	5.50	6.52	6.84	10.53	11.46
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Addus HomeCare (ADUS) — quarterly snapshot (last four years, including Q1–Q4 2025) MarketBeat analyzed Addus’ income statement, cash flow statement and balance sheet data to identify recent trends and potential risk factors for retail investors.

Revenue and margin growth: In Q4 2025, operating revenue reached $373.1M, up roughly 25–26% year over year from Q4 2024’s $297.1M, and the quarter showed improving gross and operating margins.
Gross and operating margins: Q4 2025 gross margin was about 33.0% (gross profit around $123.6M on $373.1M revenue), and the operating margin was roughly 11.3%, higher than earlier 2025 quarters.
Earnings and per‑share gains: Net income attributable to common shareholders in Q4 2025 was about $29.8M with basic EPS of $1.65 and diluted EPS of $1.62, marking stronger quarterly profitability.
Cash flow from operations: Operating cash flow was strong in 2025, led by Q3 2025 (net cash from continuing operating activities around $51.3M) and remained positive in Q4 2025 (about $18.8M), supporting liquidity.
Free cash flow and liquidity: Free cash flow remained positive across 2025 quarters, signaling the ability to fund investing activities from operations while maintaining a healthy current balance sheet.

Balance sheet composition: Total assets around $1.42B in mid‑2025, with goodwill consistently high (near $989M in Q3 2025) and total equity near $1.05B, indicating a growth‑by‑acquisition approach and substantial intangible assets.
Tax rate variability: The effective tax rate fluctuates across quarters (e.g., mid‑20s to high‑20s percentages), contributing to quarterly earnings volatility.

Financing outflows: Net cash from financing activities was negative in most 2025 quarters (e.g., Q4 2025 around -$29.0M), suggesting ongoing debt management or financing needs.
Cash balance volatility: Net change in cash and equivalents was negative in several quarters (e.g., Q4 2025 shows a decline of about $20.3M), despite positive CFO in those periods.
Impairment risk from goodwill: Goodwill remains very large (roughly $0.99B as of mid‑2025), which could pose impairment risk if reimbursement dynamics or patient volumes deteriorate.

Bottom line: Addus HomeCare has demonstrated solid revenue growth in 2025 with improving margins and positive operating cash flow. The firm maintains a strong equity position and manageable leverage, but investors should monitor ongoing financing outflows and the potential impairment risk tied to a large goodwill balance. As with many healthcare providers exposed to reimbursement and patient demand dynamics, margin and cash flow stability in future quarters will depend on volumes, labor costs, and regulatory changes.

05/21/26 12:16 PM ETAI Generated. May Contain Errors.

Addus HomeCare Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Addus HomeCare's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Addus HomeCare's net income appears to be on an upward trend, with a most recent value of $95.91 million in 2025, rising from $11.62 million in 2015. The previous period was $73.60 million in 2024. Find out what analysts predict for Addus HomeCare in the coming months.

Addus HomeCare's total operating income in 2025 was $138.62 million, based on the following breakdown:

Total Gross Profit: $461.87 million
Total Operating Expenses: $323.26 million

Over the last 10 years, Addus HomeCare's total revenue changed from $336.82 million in 2015 to $1.42 billion in 2025, a change of 322.3%.

Addus HomeCare's total liabilities were at $352.01 million at the end of 2025, a 20.4% decrease from 2024, and a 698.7% increase since 2015.

In the past 10 years, Addus HomeCare's cash and equivalents has ranged from $4.10 million in 2015 to $168.90 million in 2021, and is currently $81.62 million as of their latest financial filing in 2025.

Over the last 10 years, Addus HomeCare's book value per share changed from 12.76 in 2015 to 58.72 in 2025, a change of 360.2%.

Related Companies

Financial statements for NASDAQ:ADUS last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Financials

Financials Breakdown Chart

Key Financial Trends

Addus HomeCare Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Financials

Annual Income Statements for Addus HomeCare

Quarterly Income Statements for Addus HomeCare

Annual Cash Flow Statements for Addus HomeCare

Quarterly Cash Flow Statements for Addus HomeCare

Annual Balance Sheets for Addus HomeCare

Quarterly Balance Sheets for Addus HomeCare

Annual Metrics And Ratios for Addus HomeCare

Quarterly Metrics And Ratios for Addus HomeCare

Financials Breakdown Chart

Key Financial Trends

Addus HomeCare Financials - Frequently Asked Questions

When does Addus HomeCare's financial year end?

How has Addus HomeCare's net income changed over the last 10 years?

What is Addus HomeCare's operating income?

How has Addus HomeCare's revenue changed over the last 10 years?

How much debt does Addus HomeCare have?

How much cash does Addus HomeCare have?

How has Addus HomeCare's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools